As of 2025-07-15, the EV/EBITDA ratio of RaQualia Pharma Inc (4579.T) is 23.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4579.T's latest enterprise value is 13,673.67 mil JPY. 4579.T's TTM EBITDA according to its financial statements is 591.50 mil JPY. Dividing these 2 quantities gives us the above 4579.T EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 9.2x | 8.7x |
| Forward P/E multiples | 6.9x - 9.8x | 8.0x |
| Fair Price | 142.80 - 211.96 | 176.29 |
| Upside | -73.3% - -60.3% | -67.0% |
| Date | EV/EBITDA |
| 2025-06-13 | 26.92 |
| 2025-06-12 | 26.80 |
| 2025-06-11 | 27.34 |
| 2025-06-10 | 27.83 |
| 2025-06-09 | 27.62 |
| 2025-06-06 | 27.00 |
| 2025-06-05 | 28.99 |
| 2025-06-04 | 30.93 |
| 2025-06-03 | 29.15 |
| 2025-06-02 | 26.63 |
| 2025-05-30 | 27.09 |
| 2025-05-29 | 25.89 |
| 2025-05-28 | 25.06 |
| 2025-05-27 | 24.90 |
| 2025-05-26 | 24.61 |
| 2025-05-23 | 24.52 |
| 2025-05-22 | 23.86 |
| 2025-05-21 | 22.54 |
| 2025-05-20 | 22.70 |
| 2025-05-19 | 22.95 |
| 2025-05-16 | 19.68 |
| 2025-05-15 | 19.11 |
| 2025-05-14 | 18.86 |
| 2025-05-13 | 19.06 |
| 2025-05-12 | 18.73 |
| 2025-05-09 | 19.11 |
| 2025-05-08 | 18.15 |
| 2025-05-07 | 18.28 |
| 2025-05-02 | 18.32 |
| 2025-05-01 | 18.28 |
| 2025-04-30 | 18.49 |
| 2025-04-28 | 18.28 |
| 2025-04-25 | 18.32 |
| 2025-04-24 | 18.69 |
| 2025-04-23 | 15.38 |
| 2025-04-22 | 15.59 |
| 2025-04-21 | 15.96 |
| 2025-04-18 | 15.80 |
| 2025-04-17 | 15.09 |
| 2025-04-16 | 14.85 |
| 2025-04-15 | 14.97 |
| 2025-04-14 | 14.85 |
| 2025-04-11 | 14.76 |
| 2025-04-10 | 14.89 |
| 2025-04-09 | 13.90 |
| 2025-04-08 | 14.72 |
| 2025-04-07 | 13.48 |
| 2025-04-04 | 15.22 |
| 2025-04-03 | 15.71 |
| 2025-04-02 | 16.09 |